Literature DB >> 25466706

Improving Wait Times for Elective Chemotherapy Through Pre-Preparation: A Quality-Improvement Project at the National University Cancer Institute of Singapore.

Thomas I Peng Soh1, Yi Siew Tan2, Zarinah Hairom2, Mariana Ibrahim2, Yao Yao2, Yuet Peng Wong2, Siew Woon Lim2, Siew Eng Lim2, Boon Cher Goh2, Chee Seng Tan2.   

Abstract

PURPOSE: Cancer treatment occurs predominantly in the outpatient setting. Long wait times for chemotherapy lead to increased dissatisfaction, inefficient use of chemotherapy chairs, and compromised safety when delays result in treatment beyond operation hours. For patients who have undergone review with the necessary investigations by their oncologists on a prior day, a long wait time is more frustrating, because the sole purpose of their visit is for chemotherapy (termed elective chemotherapy). PATIENTS AND METHODS: From February 2013 to September 2013, we conducted a clinical practice improvement program project to reduce wait times for elective chemotherapy and identified late submission of prescriptions, long drug preparation time, and pharmacy review of prescriptions as the main causes of delay in our center. We formulated a workflow to pre-prepare selected chemotherapy up to 1 day before appointments. Selection was based on shelf life, cost, recyclability, and need for premedication. Patients were triaged by telephone before their appointment before pre-preparation. Participation was voluntary, with patients required to consent for liability for cost in event of wastage.
RESULTS: Average wait time for chemotherapy was significantly improved by 66% from 65.7 (median, 60; range, 5 to 301) to 22.4 minutes (median, 20; range, 0 to 80 minutes; P < .001). There were no wastages during this period, and treatment for elective patients could start as soon as the center opened if their drugs were pre-prepared the day before.
CONCLUSION: Pre-preparation of chemotherapy, together with effective phone triaging, is an effective way to reduce chemotherapy wait time.
Copyright © 2015 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2014        PMID: 25466706     DOI: 10.1200/JOP.2014.000356

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  5 in total

1.  Causes and Consequences of Chemotherapy Delays in Ambulatory Oncology Practices: A Multisite Qualitative Study.

Authors:  Megan Lafferty; Alex Fauer; Nathan Wright; Milisa Manojlovich; Christopher R Friese
Journal:  Oncol Nurs Forum       Date:  2020-07-01       Impact factor: 2.172

2.  Treatment Delays Associated With Prior Authorization for Infusible Medications: A Cohort Study.

Authors:  Zachary S Wallace; Tyler Harkness; Xiaoqing Fu; John H Stone; Hyon K Choi; Rochelle P Walensky
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-11       Impact factor: 4.794

3.  Factors and Costs Associated With Delay in Treatment Initiation and Prolonged Length of Stay With Inpatient EPOCH Chemotherapy in Patients With Hematologic Malignancies.

Authors:  Melissa K Accordino; Jason D Wright; Sowmya Vasan; Alfred I Neugut; Grace C Hillyer; Dawn L Hershman
Journal:  Cancer Invest       Date:  2017-02-06       Impact factor: 2.176

4.  Implementation of temporal lobe contouring protocol in head and neck cancer radiotherapy planning: A quality improvement project.

Authors:  Francis Ho; Jeremy Tey; David Chia; Yu Yang Soon; Chek Wee Tan; Sarahatul Bahiah; Timothy Cheo; Ivan Weng Keong Tham
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

5.  Evaluating waiting time with real-world health information in a high-volume cancer center.

Authors:  Kyu-Pyo Kim; Yu Rang Park; Jung Bok Lee; Hae Reong Kim; Yongman Lyu; Jeong-Eun Kim; Yong Sang Hong; Jae-Lyun Lee; Tae Won Kim
Journal:  Medicine (Baltimore)       Date:  2020-09-25       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.